Panna L. Sharma's most recent trade in Lantern Pharma Inc was a trade of 76,628 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Sept. 19, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lantern Pharma Inc | Panna L. Sharma | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Sep 2025 | 76,628 | 0 | - | - | Stock Option (Right to Buy) | |
| Lantern Pharma Inc | Panna L. Sharma | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2025 | 76,628 | 76,628 | - | - | Stock Option (Right to Buy) | |
| Lantern Pharma Inc | Panna L. Sharma | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 70,000 | 70,000 | - | - | Stock Option (Right to Buy) | |
| Lantern Pharma Inc | Panna L. Sharma | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) |